Nuvectra Corp Company Profile (NASDAQ:NVTRV)

About Nuvectra Corp (NASDAQ:NVTRV)

Nuvectra Corp logoNuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Bio Medical Devices
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVTRV
  • CUSIP: N/A
  • Web:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Net Margins: -155.59%
  • Return on Equity: -63.77%
  • Return on Assets: -46.40%

Frequently Asked Questions for Nuvectra Corp (NASDAQ:NVTRV)

What is Nuvectra Corp's stock symbol?

Nuvectra Corp trades on the NASDAQ under the ticker symbol "NVTRV."

Who are some of Nuvectra Corp's key competitors?

How do I buy Nuvectra Corp stock?

Shares of Nuvectra Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

MarketBeat Community Rating for Nuvectra Corp (NASDAQ NVTRV)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Nuvectra Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Nuvectra Corp (NASDAQ:NVTRV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Nuvectra Corp (NASDAQ:NVTRV)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/3/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for Nuvectra Corp (NASDAQ:NVTRV)
No earnings announcements for this company have been tracked by


Earnings Estimates for Nuvectra Corp (NASDAQ:NVTRV)

No earnings estimates for this company have been tracked by


Dividend History for Nuvectra Corp (NASDAQ:NVTRV)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Nuvectra Corp (NASDAQ:NVTRV)
No insider trades for this company have been tracked by


Headline Trends for Nuvectra Corp (NASDAQ:NVTRV)
Latest Headlines for Nuvectra Corp (NASDAQ:NVTRV)
No headlines for this company have been tracked by



Nuvectra Corp (NVTRV) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by Staff